PortfoliosLab logoPortfoliosLab logo
IONQ vs. VRTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

IONQ vs. VRTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in IonQ, Inc. (IONQ) and Vertex Pharmaceuticals Incorporated (VRTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IONQ achieves a 28.93% return, which is significantly higher than VRTX's -1.86% return.


IONQ

1D
-0.24%
1M
11.36%
YTD
28.93%
6M
14.90%
1Y
52.88%
3Y*
75.90%
5Y*
40.49%
10Y*

VRTX

1D
-0.03%
1M
1.83%
YTD
-1.86%
6M
-1.57%
1Y
-2.31%
3Y*
9.16%
5Y*
18.18%
10Y*
17.15%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IONQ vs. VRTX - Yearly Performance Comparison


2026 (YTD)20252024202320222021
IONQ
IonQ, Inc.
28.93%7.42%237.13%259.13%-79.34%50.11%
VRTX
Vertex Pharmaceuticals Incorporated
-1.86%12.58%-1.03%40.90%31.50%-7.08%

Correlation

The correlation between IONQ and VRTX is 0.00, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.00

Correlation (3Y)
Calculated over the trailing 3-year period

0.11

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (All Time)
Calculated using the full available price history since Jan 4, 2021

0.15

The correlation between IONQ and VRTX shifts across timeframes, from 0.00 (1 year) to 0.15 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

IONQ:

$21.48B

VRTX:

$114.03B

EPS

IONQ:

$0.86

VRTX:

$16.87

PE Ratio

IONQ:

67.11

VRTX:

26.38

PS Ratio

IONQ:

99.37

VRTX:

9.34

PB Ratio

IONQ:

4.32

VRTX:

4.31

Total Revenue (TTM)

IONQ:

$187.12M

VRTX:

$12.26B

Gross Profit (TTM)

IONQ:

$71.25M

VRTX:

$10.57B

EBITDA (TTM)

IONQ:

$405.86M

VRTX:

$5.19B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IONQ vs. VRTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IONQ
IONQ Risk / Return Rank: 6161
Overall Rank
IONQ Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
IONQ Sortino Ratio Rank: 6666
Sortino Ratio Rank
IONQ Omega Ratio Rank: 6262
Omega Ratio Rank
IONQ Calmar Ratio Rank: 5959
Calmar Ratio Rank
IONQ Martin Ratio Rank: 5757
Martin Ratio Rank

VRTX
VRTX Risk / Return Rank: 3737
Overall Rank
VRTX Sharpe Ratio Rank: 3939
Sharpe Ratio Rank
VRTX Sortino Ratio Rank: 3434
Sortino Ratio Rank
VRTX Omega Ratio Rank: 3535
Omega Ratio Rank
VRTX Calmar Ratio Rank: 3838
Calmar Ratio Rank
VRTX Martin Ratio Rank: 3737
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IONQ vs. VRTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for IonQ, Inc. (IONQ) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


IONQVRTXDifference
Sharpe ratioReturn per unit of total volatility

+0.63

Sortino ratioReturn per unit of downside risk

+1.33

Omega ratioGain probability vs. loss probability

1.16

1.02

+0.14

Calmar ratioReturn relative to maximum drawdown

0.73

-0.14

+0.88

Martin ratioReturn relative to average drawdown

1.33

-0.29

+1.63

IONQ vs. VRTX - Sharpe Ratio Comparison

The current IONQ Sharpe Ratio is 0.53, which is higher than the VRTX Sharpe Ratio of -0.10. The chart below compares the historical Sharpe Ratios of IONQ and VRTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

IONQ vs. VRTX - Drawdown Comparison

The maximum IONQ drawdown since its inception was -90.00%, roughly equal to the maximum VRTX drawdown of -91.77%. Use the drawdown chart below to compare losses from any high point for IONQ and VRTX.


Loading charts...

Drawdown Indicators


IONQVRTXDifference

Max Drawdown

Largest peak-to-trough decline

-90.00%

-91.77%

+1.77%

Max Drawdown (1Y)

Largest decline over 1 year

-67.61%

-23.56%

-44.05%

Max Drawdown (3Y)

Largest decline over 3 years

-67.61%

-29.07%

-38.54%

Max Drawdown (5Y)

Largest decline over 5 years

-90.00%

-29.07%

-60.93%

Max Drawdown (10Y)

Largest decline over 10 years

-41.60%

Current Drawdown

Current decline from peak

-29.53%

-13.90%

-15.63%

Average Drawdown

Average peak-to-trough decline

-50.88%

-37.73%

-13.15%

Ulcer Index

Depth and duration of drawdowns from previous peaks

37.20%

11.30%

+25.90%

Volatility

IONQ vs. VRTX - Volatility Comparison

IonQ, Inc. (IONQ) has a higher volatility of 31.60% compared to Vertex Pharmaceuticals Incorporated (VRTX) at 7.47%. This indicates that IONQ's price experiences larger fluctuations and is considered to be riskier than VRTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IONQVRTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

31.60%

7.47%

+24.13%

Volatility (6M)

Calculated over the trailing 6-month period

68.80%

20.71%

+48.09%

Volatility (1Y)

Calculated over the trailing 1-year period

93.28%

34.13%

+59.15%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

100.48%

28.53%

+71.95%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

97.53%

32.82%

+64.71%

Dividends

IONQ vs. VRTX - Dividend Comparison

Neither IONQ nor VRTX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

IONQ vs. VRTX - Financials Comparison

This section allows you to compare key financial metrics between IonQ, Inc. and Vertex Pharmaceuticals Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00B2.50B3.00B3.50B20222023202420252026
64.67M
2.99B
(IONQ) Total Revenue
(VRTX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


IONQ and VRTX have a correlation of 0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IONQ has higher volatility (31.60%) compared to VRTX (7.47%). In terms of maximum drawdown, IONQ dropped -90.00% vs VRTX's -91.77%.

IONQ currently has the higher Sharpe Ratio (0.53 vs -0.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IONQ and VRTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer